M3, Inc.
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 14 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Top Mutual Funds / ETFs
Updated 2026/01/11Major Holders
Updated 2026/01/11| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
MFS SERIES TRUST X-MFS International Intrinsic Value Fund
|
11.7M | -0.50% | |
|
HARDING LOEVNER Fd.S INC-Harding Loevner Intl Eqy. PORT.
|
8.2M | +1.00% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
6.0M | +0.55% | |
|
John Hancock Funds III-International Growth Fund
|
4.0M | +10.37% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
3.8M | +2.69% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
3.0M | +1.04% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
3.6K | +1.52% |
Dividend History
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥21 | 0.0% |
| 2024 | ¥21 | +10.5% |
| 2023 | ¥19 | +18.8% |
| 2022 | ¥16 | +33.3% |
| 2021 | ¥12 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥208,159M | ¥230,818M | ¥238,883M | ¥284,900M |
| Gross Profit | ¥123,268M | ¥135,186M | ¥140,531M | ¥154,364M |
| Operating Income | ¥66,222M | ¥70,511M | ¥63,024M | ¥60,299M |
| Pretax Income | ¥96,239M | ¥74,387M | ¥69,231M | ¥65,502M |
| Net Income | ¥63,845M | ¥49,028M | ¥45,271M | ¥40,484M |
| EPS | ¥93.98 | ¥72.17 | ¥66.63 | ¥59.60 |
| Operating Margin | 31.81% | 30.55% | 26.38% | 21.16% |
| Balance Sheet | ||||
| Total Assets | ¥345,981M | ¥400,645M | ¥490,780M | ¥581,741M |
| Total Equity | ¥257,840M | ¥302,630M | ¥351,915M | ¥378,436M |
| Total Liabilities | ¥88,141M | ¥98,015M | ¥138,865M | ¥203,305M |
| Cash | ¥104,253M | ¥118,319M | ¥149,661M | ¥134,933M |
| Interest-bearing Debt | - | ¥111M | ¥18,514M | ¥24,420M |
| Equity Ratio | 74.52% | 75.54% | 71.71% | 65.05% |
| D/E Ratio | 0.00 | 0.00 | 0.05 | 0.06 |
| Cash Flow | ||||
| Operating CF | ¥52,108M | ¥57,113M | ¥58,310M | ¥51,743M |
| Investing CF | -¥23,407M | -¥21,933M | -¥39,456M | -¥39,149M |
| Financing CF | -¥16,371M | -¥22,837M | ¥9,432M | -¥27,165M |
| Free CF | ¥48,891M | ¥51,759M | ¥50,729M | ¥42,752M |
| Efficiency | ||||
| ROE | 24.76% | 16.20% | 12.86% | 10.70% |
| ROA | 18.45% | 12.24% | 9.22% | 6.96% |
Latest IR Information
-
Notice Regarding the Status of Treasury Stock Acquisition (Based on the Provisions of Article 459, Paragraph 1 of the Companies Act concerning Treasury Stock Acquisition under the Articles of Incorporation)
In December 2025, 160,400 shares of treasury stock were acquired for a total of 348,267,200 yen, bringing the cumulative number of shares acquired to 1,760,500 shares and the total acquisition cost to 3,654,534,500 yen.
Read more -
Notice Regarding the Grant of U Stock Options (Stock Acquisition Rights)
M3, Inc. has introduced a stock option plan granting 155 stock acquisition rights, each representing 100 common shares, free of charge to one employee.
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥2,714
Rating Score: 2.07 (Based on 14 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
M3, Inc. provides medical-related services to physicians and other healthcare professionals through the internet. It operates m3.com, a members-only website for providing information, tools, and services for medical professionals; MR-kun which delivers the latest medical information for daily medical practice; QOL-kun, a marketing support service that provides selected information useful for doctors; m3.com CAREER, a physician recruitment and career change support site; and Drug Carrier, a job information site for pharmacists. The company also provides online lectures; clinical trial; research targeting domestic medical professionals; medical-related self-planned data and research reports; global health professional research; survey panel provision services; and m3.com opening and management services. In addition, it offers AskDoctors, where registered doctors answer questions about health and illness from the public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides services for pharmaceutical companies; and drug information database. Further, the company is involved in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; Support for recruiting subjects necessary for clinical development and clinical research, and related tasks; provision of management support to medical institutions, as well as visiting nursing, day care, and home care support services; and operates podiatry and venous disease clinics, and hospice facilities. Additionally, it offers clinical and medico-political news and education for medical professionals. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.